The Endo/Multi Bundle is a comprehensive combination of medical devices designed to facilitate the identification and measurement of various quality measures within the healthcare system. These devices are strategically integrated to assist healthcare providers in assessing and enhancing patient care quality. The bundle typically includes various cutting-edge tools and technologies, each tailored to address specific quality measures.

These devices are meticulously selected to cover a spectrum of quality indicators, including patient safety, effectiveness of care, patient experience, and health outcomes. By utilizing this package, healthcare providers can efficiently collect data, monitor performance, and track progress meeting quality standards. The ultimate goal is to improve the overall quality of care, enhance patient outcomes, and ensure that healthcare organizations deliver evidence-based, effective, patient-centered services. The bundle empowers providers with the tools and data to drive continuous quality improvement, ultimately leading to better healthcare experiences and patient health outcomes:

1. The Diabetic Retinopathy Exam (DRE) Diabetic Retinopathy is an eye condition that can cause vision loss and blindness in people and should not be confused with an ophthalmoscope eye exam. 50% of diabetic patients lack documentation of a retinal eye exam which is the most difficult HEDIS measure to meet. Therefore, insurance companies are grateful for assistance to close the quality measure in care. A fundus camera, also known as a retinal camera, is a specialized medical device that captures high-resolution retina images, enabling healthcare providers to detect and monitor retinopathy and other retinal conditions more effectively. 

2. The Diabetic Neuropathy Device™ is a groundbreaking FDA-cleared innovation that serves as a comprehensive solution for identifying and measuring peripheral neuropathy for both large and small fiber neuropathy. This device is a game-changer in the field of diabetic neuropathy, offering a multi-objective approach that enhances precision and accuracy in diagnosis. With this innovative device, healthcare professionals can provide earlier and more effective intervention to patients with diabetic neuropathy, who previously had limited options for treatment. This device is a true breakthrough in medical technology, and it has the potential to significantly improve the lives of those suffering from this debilitating condition.

3. The CardioANS (ANS) is an FDA-cleared medical device that measures arterial stiffness, vascularization, and endothelial function. It evaluates the functioning of the Autonomic Nervous System, which regulates many of the body's internal processes, providing accurate and reliable data to help doctors make informed decisions about their patients' health.

4. The Peripheral Artery Disease (PAD) is a condition that affects the arteries supplying blood to the legs. TruPAD™ is a medical device that can be used to measure and diagnose PAD. This condition occurs when the arteries become narrow or clogged with plaque, which can constrict blood flow. If left untreated, PAD can lead to serious complications, such as leg pain, difficulty walking, and even amputation. However, early detection and treatment can help prevent these complications and improve overall quality of life. Using TruPAD™ is a great way to monitor and manage this condition, and it can be a valuable tool for healthcare professionals and patients alike.

The inclusion of invaluable components, such as the Diabetic Retinopathy Exam (DRE) and the Diabetic Neuropathy Device™ (DND), brings transformative potential to the practice of healthcare. While the Diabetic Retinopathy Exam (DRE) provides critical insights into patients' retinal health, the Diabetic Neuropathy Device™ (DND) revolutionizes identifying and measuring small-fiber and large-fiber diabetic neuropathy. Healthcare providers can drive continuous quality improvement with groundbreaking tools and devices like the Autonomic Nervous System (ANS) and TruPAD™ for peripheral artery disease (PAD). This holistic approach aims to enrich the healthcare experience and elevate patient health outcomes, ensuring a brighter and healthier future for all. 

...

Features of the Tests:

• Non-Invasive

• <3-minutes each to complete

• FDA Cleared with recommended billing codes

• Easy to interpret color-coded reports

• Allows provider to perform and bill for up to 8 billing codes